Presented by GE HealthCare
Earlier this year, GE HealthCare announced Health Canada's approval of Omnipaque injection for Oral use, making it the first and only low-osmolar iodinated contrast media approved for oral use in Canada. Omnipaque injection for Oral Use is indicated in adults and pediatrics 1. Read More